Prognostic impact of genetic mutations in unfavorable cancer of unknown primary site

被引：0
|
作者：
Tang, Chengyu [1 ,2 ]
Lu, Hsueh-Ju [3 ,4 ]
Liu, Hsuan [5 ,6 ,7 ,8 ]
Huang, Chi-Ying [9 ]
Chang, Peter Mu-Hsin [1 ,2 ,9 ]
机构：
[1] Taipei Vet Gen Hosp, Div Med Oncol, Dept Oncol, Taipei, Taiwan
[2] Natl Yang Ming Chiao Tung Univ, Sch Med, Taipei, Taiwan
[3] Chung Shan Med Univ Hosp, Div Med Oncol, Dept Internal Med, Taichung, Taiwan
[4] Chung Shan Med Univ, Sch Med, Taichung, Taiwan
[5] Chang Gung Univ, Grad Inst Biomed Sci, Coll Med, Taoyuan, Taiwan
[6] Chang Gung Mem Hosp, Div Colon & Rectal Surg, Lin Kou Med Ctr, Taoyuan, Taiwan
[7] Chang Gung Univ, Mol Med Res Ctr, Taoyuan, Taiwan
[8] Chang Gung Univ, Dept Cell & Mol Biol, Coll Med, Taoyuan, Taiwan
[9] Natl Yang Ming Chiao Tung Univ, Inst Biopharmaceut Sci, Taipei, Taiwan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.247
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MO36-4
引用
收藏
页码：S1419 / S1419
页数：1
相关论文
共 50 条
  • [41] AKT as Locus of Cancer Unknown Primary Site
    Radisavljevic, Ziv
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2016, 117 (05) : 1066 - 1068
  • [42] Inflammation as a validated prognostic determinant in carcinoma of unknown primary site
    Z Mohamed
    D J Pinato
    F A Mauri
    K-W Chen
    P M-H Chang
    R Sharma
    British Journal of Cancer, 2014, 110 : 208 - 213
  • [43] New Prognostic Index to Predict Survival in Patients with Cancer of Unknown Primary Site with Unfavourable Prognosis
    Trivanovic, D.
    Petkovic, M.
    Stimac, D.
    CLINICAL ONCOLOGY, 2009, 21 (01) : 43 - 48
  • [44] Cancer of unknown primary site: Missing primary or missing biology?
    Pentheroudakis, George
    Briasoulis, Evangelos
    Pavlidis, Nicholas
    ONCOLOGIST, 2007, 12 (04): : 418 - 425
  • [45] Exceptional response to immunotherapy monotherapy in a patient with an unfavorable subset of cancer of unknown primary
    Huang, Xiangzhong
    Ren, Dongqing
    Sun, Qiulian
    Xu, Xinjian
    Ding, Yiwen
    QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2023, 13 (12) : 8832 - 8838
  • [46] Prognostic impact of primary tumor site location in metastatic colorectal cancer (mCRC).
    Matos, Ignacio
    Ortiz, Carolina
    Elez, Elena
    Argiles, Guillem
    Grasselli, Julieta
    Macarulla, Teresa
    Capdevila, Jaume
    Alsina, Maria
    Sauri, Tamara
    Hierro, Cinta
    Verdaguer, Helena
    Sanz-Garcia, Enrique
    Maria Martinez, Ana
    Espin, Eloy
    Dopazo, Cristina
    Landolfi, Stefania
    Nuciforo, Paolo
    Vivancos, Ana
    Dienstmann, Rodrigo
    Tabernero, Josep
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [47] Cancer of unknown primary site with pathological characteristic of the breast cancer
    Goto, Keiko
    Hashimoto, Jun
    Tanabe, Yuko
    Kodaira, Makoto
    Yamamaoto, Harukaze
    Yunokawa, Mayu
    Yonemori, Kan
    Shimizu, Chikako
    Tamura, Kenji
    Fujiwara, Yasuhiro
    ANNALS OF ONCOLOGY, 2015, 26 : 111 - 112
  • [48] Immunological evaluation of personalized peptide vaccination for patients with histologically unfavorable carcinoma of unknown primary site
    Shinjiro Sakamoto
    Shigeru Yutani
    Shigeki Shichijo
    Michi Morita
    Akira Yamada
    Kyogo Itoh
    Masanori Noguchi
    Cancer Immunology, Immunotherapy, 2016, 65 : 1223 - 1231
  • [49] Prognostic Factors in Patients With Cancer of Unknown Primary (CUP)
    Petrakis, D.
    Voulgaris, E.
    Pentheroudakis, G.
    Pavlidis, N.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S673 - S673
  • [50] Immunological evaluation of personalized peptide vaccination for patients with histologically unfavorable carcinoma of unknown primary site
    Sakamoto, Shinjiro
    Yutani, Shigeru
    Shichijo, Shigeki
    Morita, Michi
    Yamada, Akira
    Itoh, Kyogo
    Noguchi, Masanori
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2016, 65 (10) : 1223 - 1231
12345